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ABSTRACT The mechanism of CD8 cooperation with the TCR in antigen recognition was studied on live T cells.
Fluorescence correlation measurements yielded evidence of the presence of two TCR and CD8 subpopulations with different
lateral diffusion rate constants. Independently, evidence for two subpopulations was derived from the experimentally observed
two distinct association phases of cognate peptide bound to class I MHC (pMHC) tetramers and the T cells. The fast phase rate
constant ((1.7 6 0.2) 3 105 M1 s1) was independent of examined cell type or MHC-bound peptides’ structure. Its value was
much faster than that of the association of soluble pMHC and TCR ((7.0 6 0.3) 3 103 M1 s1), and close to that of the
association of soluble pMHC with CD8 ((1–2)3 105 M1 s1). The fast binding phase disappeared when CD8-pMHC interaction
was blocked by a CD8-speciﬁc mAb. The latter rate constant was slowed down ;10-fold after cells treatment with methyl-b-
cyclodextrin. These results suggest that the most efﬁcient pMHC-cell association route corresponds to a fast tetramer binding to
a colocalized CD8-TCR subpopulation, which apparently resides within membrane rafts: the reaction starts by pMHC
association with the CD8. This markedly faster step signiﬁcantly increases the probability of pMHC-TCR encounters and thereby
promotes pMHC association with CD8-proximal TCR. The slow binding phase is assigned to pMHC association with a noncolocali-
zed CD8-TCR subpopulation. Taken together with results of cytotoxicity assays, our data suggest that the colocalized, raft-
associated CD8-TCR subpopulation is the one capable of inducing T-cell activation.
INTRODUCTION
The interaction between the TCR expressed on the surface of
CD81 T-lymphocytes and its ligand, peptide-class I MHC
complexes (pMHC) on APCs is central to the positive
selection and activation of these cells. This interaction is
endowed with a high speciﬁcity, usually paralleled by
modest afﬁnities (1–4). Already at this early stage of T-cell
interactions with the APC, additional, non-antigen-speciﬁc
interactions take place between the T-cell surface glycopro-
tein CD8 and the pMHC ligand (5). Due to its important role
in TCR-ligand interaction and signal transduction, CD8 is
considered to be a TCR coreceptor (6–9). Three-dimensional
structure analysis of TCR-pMHC complexes revealed that
the TCRab heterodimer binds to the a1 and a2 domains of
the MHC heavy chain and to exposed side chains of the
peptide bound in the ‘‘groove’’ (1,10,11). In contrast, CD8
binds to conserved areas, distal to the ‘‘groove’’ on the a2
and a3 domains of MHC heavy chain and on b2-micro-
globulin (12,13). Though a consensus exists about the ﬁnal
outcome of the CD8-pMHC interactions for tetramer binding
and T-cell activation (7,14–16) the mechanism of CD8
function is still debated (17). Data obtained for the
interactions between soluble pMHC, TCR, and CD8
molecules failed to detect an enhancement of TCR-pMHC
afﬁnity due to the latter interaction with CD8 (18). There-
fore, CD8 and TCR interact independently with their pMHC
ligand. It is known that the CD8-pMHC afﬁnity is signif-
icantly lower than that of the TCR-pMHC.Nevertheless, CD8
was shown to dramatically increase association of pMHC
tetramers with T cells (5,14,19). A recent study has provided
evidence that optimal binding of pMHC multimers to live T
cells requires ‘‘simultaneous engagement’’ of CD8 and TCR
(5). However, the detailed mechanism by which CD8 promo-
tes pMHC-cell association has not been resolved.
Resolution of the earliest events of T-cell-ligand inter-
actions should take into account the following biophysical
parameters: a), cell surface density and mobility of the TCR
and CD8, b), their spatial relationship, and c), afﬁnities and
kinetic parameters of these interactions. Both the low ex-
pression levels of CD8 and TCR (in the range of 104 copies
per cell (20)), as well as the relatively low afﬁnities of the
pMHC-TCR (0.1–100 mM) and pMHC-CD8 (10–100 mM)
interactions (9,21,21,22) make their direct measurements on
live cells in real time a considerable challenge.
Recent progress made in ﬂuorescence correlation spec-
troscopy (FCS) offers an invaluable experimental possibility
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for investigating molecular events such as diffusion of cel-
lular membrane components (23–26). The method is based
on monitoring intensity ﬂuctuations of a ﬂuorescence probe
carried by a molecule of interest in an extremely small
volume selected by a sharply focused laser beam on the cell
surface. We have now employed FCS for noninvasive mea-
surements of the diffusion processes taking place on the
T-cell plasma membrane. These were complemented by
time-resolved measurements of the pMHC-TCR or CD8
interactions carried out using ﬂuorescent pMHC tetramers
(pMHC)4 (27). The use of tetramers circumvents, at least
partly, problems caused by their intrinsic low afﬁnity, as
tetramers avidity yields higher binding than that of mono-
meric pMHC complexes and allows monitoring directly the
time courses of their association and dissociation.
Two different T-cell systems were investigated: 1), a hy-
bridoma cell line expressing the T1 TCR and CD8 (28) (the
interaction of TCR T1 recombinant soluble form with
cognate pMHC complex have earlier been studied (29)), and
2), two CTL clones (30). Studies of the latter allowed cor-
relating the obtained biophysical parameters with cytotoxic
function. A model where CD8 plays a major role in pMHC
binding to T cells is proposed.
MATERIALS AND METHODS
Cell lines, antibodies, and chemicals
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich
(Rehovot, Israel). The CD8ab transfected T1.4 hybridoma cells have been
described previously (28). The cells were cultured in DMEM (GibcoBRL,
Paisley, Scotland) supplemented with 10% fetal calf serum (GibcoBRL),
2 mM L-glutamine, 1 mM sodium pyruvate, combined antibiotics (Bio-Lab,
Jerusalem, Israel), and 50 mM b-mercaptoethanol in a humidiﬁed
atmosphere with 7% CO2 at 37C. CD81 DBA/2 CTL clones (CAS1 and
CAS20) were raised against syngeneic (H-2d) P815 tumor cells transfected
with the HLA-Cw3 gene as target cells, as described earlier (30). The clones
were cultured in RPMI-1640 (GibcoBRL) supplemented with 10% fetal calf
serum, 2 mM L-glutamine, 1 mM sodium pyruvate, combined antibiotics,
and 50 mM b-mercaptoethanol in a humidiﬁed atmosphere with 5% CO2 at
37C. The cells were stimulated every one or two weeks with 1 3 104 Rad
irradiated 2 3 106 target cells, 2 3 103 Rad irradiated 20 3 106 DBA/2
splenocytes (per 15 ml medium), and 20 units/ml IL-2 (ProSpec-Tany
TechnoGene, Rehovot, Israel). CD3-speciﬁc mAb labeled with CyChrome
(clone 17A2) was purchased from PharMingen (San Diego, CA). CD8-
speciﬁc mAb (clone 53-6.7) labeled with SPRD was purchased from
Southern Biotechnologies (Birmingham, AL). Puriﬁed and allophycocya-
nin-labeled CD8-speciﬁc mAb (clone CT-CD8a) was purchased from
CALTAG Laboratories (Burlingame, CA). TCRb-chain speciﬁc mAb
(clone H57 American hamster IgG) was purchased from American Type
Culture Collection (Manassas, VA). Fab fragments preparation protocol (31)
was as follows: 1 mg of the H57 mAbs were digested into Fab with papain
(Sigma, St. Louis, MO) in digesting buffer (PBS, 0.01 M EDTA, 0.1 M
cystein, papain, mAb/enzyme ratio 100:1). The reaction was stopped by
adding iodoacetamide (0.03 M ﬁnal concentration). The product was
puriﬁed by the passage through a protein G column to remove possibly
remaining intact IgG and Fc fragment. These Fab preparations were
conﬁrmed to form a single band with 50 kDa on SDS-PAGE. The digested
samples were labeled with either Cy3 or Cy5 and puriﬁed on a GD10 gel
ﬁltration column (Amersham Pharmacia Biotech, Petach Tikva, Israel) and
then by gel ﬁltration on Superdex 200 column (1 3 30 cm, Amersham
Pharmacia Biotech), in 20 mM TRIS, 150 mM NaCl, pH 8. The dye/protein
ratio was 1–1.5 for both dyes. Fluorescein-5-isothiocyanate labeled cholera
toxin B subunit (CTB-FITC) was purchased from Sigma.
Preparation of peptides and peptide-loaded
H-2Kd tetramers
Peptides
The pCw3 derived from HLA-Cw3 (residues 170–179, RYLKNGKETL)
was synthesized by automated solid-phase methodology on an Applied
Biosystems (Foster City, CA) model 432A synthesizer, using the manu-
facturer’s standard Fmoc protocol, and puriﬁed by high-performance liquid
chromatography. Synthesis and puriﬁcation of the peptide azido benzoic
acid derivative SYIPSAEK(ABA)I, (pPbCSABA), from Plasmodium berghei
circumsporozoite protein (residues 252–260), was described elsewhere (32).
H-2K d tetramers
Peptide-loaded tetramers were produced by reacting biotinylated H-2Kd/
pPbCSABA or H-2Kd/pCw3 complexes with PE-labeled streptavidin
(Molecular Probes, Eugene, OR) as described elsewhere (19). The labeled
tetramers were puriﬁed on a Superdex 200 column, which was eluted in Tris
buffer (20 mM, pH 7.5, 150 mM NaCl, 0.1% NaN3).
Fluorescence correlation and confocal
microscopy measurements
Fluorescence correlation measurements were performed with confocal
illumination of a volume element of 0.2 ﬂ on a ConfoCor2 instrument (Carl
Zeiss, Jena, Germany) as described elsewhere (26). A 403 N.A. 1.2
C-Apochromat water immersion objective and 78-mm pinhole were used. To
studyTCRandCD8diffusion properties, theT1.4 orCTLclones (106 cell/ml)
were reacted with Cy3, SPRD, or CyChrome-labeled speciﬁc antibodies for
40 min on ice in PBS containing 3% fetal calf serum and 0.02% NaN3 then
washed 33 with the same buffer. The cells were kept on ice before the
measurements and 40 ml of the cell samples were loaded on a borosilicate
coverslip (Marienfeld, Lauda-Ko¨nigshofen, Germany) and measurements
proceeded for 5 min at room temperature. The ﬂuorescence intensity
ﬂuctuations were recorded for 30-s intervals and each measurement was
repeated 5–10 times. Special care was taken to acquire ﬂuorescence ﬂuc-
tuations without drift in the baseline. The two-dimensional (2D) auto-
correlation functionG(t) was analyzed according to the following equations:
GðtÞ ¼ 11 1
N
+
3
i¼1
ai
11 t=ti
+
3
i¼1
ai
; (1)
where N is the number of ﬂuorescent particles in the illuminated spot on the
cell-membrane surface, ai is a fraction of ﬂuorescence molecules with ti
diffusion time constants using GLSA optimization program (Alango, Haifa,
Israel). The diffusion constants were calculated as
kDi ¼ v2=4ti; (2)
where the beam waist v was 0.20 mm. The experimental errors are speciﬁed
as two standard deviations from the mean values (mean 6 SD 2s). The
apparatus was calibrated by measuring diffusion of rhodamine B in water
(280 mm2/s). Confocal microscopy measurements were performed with
Radiance2100 (Bio-Rad, Cambridge, MA) equipped with a 403 oil immer-
sion objective and an Argon-ion laser using excitations of 488 nm for FITC
and Cy3 and 543 nm for CyChrome and SPRD.
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Time-resolved measurements of pMHC tetramers
interaction with T cells
Reactions were initiated by adding 1–10 ml of tetramer solution (2 mM) to
200 ml cell suspension (107 cell/ml) at 24C. At the indicated time points, 10
ml aliquots of the cell-tetramer mixtures were diluted to 1 ml in cold PBS
(4C) containing 3% fetal calf serum and 0.02% NaN3. These 100-fold
dilutions reduced the unbound tetramer concentrations to the picomolar level
so that its contribution to the background ﬂuorescence signal was ,5–10%
of that due to the speciﬁcally bound fraction. The cell-associated ﬂuo-
rescence intensity was then analyzed for 15-s intervals by ﬂow cytometry
(FACSort, Becton-Dickinson, Franklin Lakes, NJ) using CellQuest soft-
ware. The experimental time courses were produced by plotting ﬂuorescence
mean values versus time and analyzed by the GLSA optimization program
using a two-exponential model:
IðtÞ ¼ a01 +
2
i¼1
ai  expðt  kiÞ; (3)
where ai and ki are the amplitudes and corresponding apparent rate constants,
respectively, and a0 is a constant.
To investigate the tetramer dissociation kinetics we used the following
dilution protocol: 200 ml of CTLs or the hybridoma T-cell suspensions (107
cell/ml) were preincubated for 2 h with their speciﬁc pMHC tetramers (ﬁnal
concentration 20 nM) at the indicated temperatures, in PBS containing 3%
fetal calf serum and 0.02% NaN3. Then, 80 ml cell samples were diluted into
1 ml of the same buffer containing CD8-speciﬁc antibodies (CT-CD8a, ﬁnal
concentration 0.15 mM) preventing tetramer rebinding to the cells. The time
course of changes in cell-associated ﬂuorescence was measured by ﬂow
cytometry for 15-s intervals.
Cells treatment with methyl-b-cyclodextrin
T1.4 CD8ab1 cells were washed once with PBS, suspended at 23 106 cell/
ml, and incubated for 1 h in a humidiﬁed atmosphere with 5% CO2 at 37C
with serum-free DMEM in the absence (controls) or presence (treated cells)
of 5 mMMbCD. The cells were then washed once in PBS and suspended at
;107 cell/ml in PBS containing 3% fetal calf serum and 0.02% NaN3 and
subjected to ﬂow cytometry measurements as above.
Cytotoxicity assay
CAS1 and CAS20 CTL clones were tested in a 4-h [51Cr]-release assay. The
experiments were carried out using 5000 target cells per well at 0.1–30 E/T
ratios. The percentage of speciﬁc lysis was calculated as: (experimental-
spontaneous release)/(total-spontaneous release) 3 100%. All experiments
were performed in triplicates and repeated two to three times.
RESULTS
Expression levels of TCR and CD8 do not
correlate with cytotoxic activity
Interaction of CD8 with its pMHC ligand is known to sig-
niﬁcantly increase the cytotoxic response and decrease the
threshold of CTL activation. However, no cooperativity has
been revealed in the interactions among recombinant, solu-
ble pMHC, CD8, and TCR (18). Hence, CD8 and TCR in-
dependently bind to the same pMHC molecule. Therefore, if
both CD8 and TCR are independently and homogeneously
distributed, T-cell responsiveness would be a function of the
TCR and CD8 average surface densities on the cell’s
membrane and of their individual mobilities. The lack of
such a straightforward dependence may therefore indicate
heterogeneity and/or interdependence of the CD8 and TCR
membrane localization. To investigate these possibilities we
have measured TCR and CD8 expression levels and exam-
ined their relation to the CTL killing efﬁcacy of the CAS1
and CAS20 clones. The surface expression level of CD8,
monitored by ﬂow cytometry, was found to be approxi-
mately fourfold higher than that of TCR (ﬂuorescence
efﬁciency of CyChome and SPRD tags of the CD3- and
CD8-speciﬁc mAbs, which are different trademarks for the
same PE-Cy5 conjugate, were found to be about equal by
quantitative ﬂuorimetric measurements). Both CD8 and TCR
expression levels are found to depend on the time elapsed
after cell stimulation (Fig. 1 A). Both CD8 and TCR levels
exhibited a transient increase with maxima on the 3rd to 4th
day after stimulation, followed by an eightfold decrease for
CD8 and a 10-fold decrease for TCR on the 11th to 12th day.
To ascertain that the observed changes result from an alter-
ation of the protein’s surface density and are not due to a
change in the cell’s size, we compared confocal images of
these cells on different poststimulation (PS) days. Fig. 1 B
shows that the changes are indeed caused primarily by a
signiﬁcant reduction in cell surface density of these proteins.
As a reference, TCR and CD8 expression levels were mea-
sured on T1.4 hybridoma cells, which remained unchanged
over time.
Next, CTL killing efﬁciency was determined by measure-
ments of speciﬁc lysis of the (H-2d) P815 tumor cells
transfected with the HLA-Cw3 gene and expressing H-2Kd/
pCw3 complexes on the cell surface or H-2d transfected
RMA-S cells using the 51Cr release assay. The latter cells,
expressing peptide ‘‘empty’’ H-2Kd molecules on the cell
surface, were loaded with different pCw3 concentrations.
CAS20 cells exhibited the highest killing efﬁcacy for the
P815 targets. As expected, the higher surface densities of
H-2Kd/pCw3 on the APCs correlated with higher chromium
release (Fig. 1 C). Nevertheless, no such a relationship was
observed with the surface densities of TCR and CD8; killing
experiments were carried out on the days where the surface
expressions of the latter molecules were signiﬁcantly
different (4th and 11th PS days). We did not resolve higher
lytic efﬁcacy on the 4th PS day when the CD8 and TCR
expression levels were signiﬁcantly higher. Moreover, the
lytic efﬁcacy was higher on the 11th day when the inﬂexion
point in the cytotoxic titration curve was reached at;0.3 E/T
ratio, whereas on the 4th day this was observed only at;1 E/
T ratio (Fig. 1 D).
Lateral diffusion and cell-surface distributions of
TCR and CD8 are heterogeneous
The above-described lack of correlation between the cellular
cytotoxicity and the expression levels of TCR and CD8 led
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us to investigate the lateral mobility of these molecules on
the cell’s surface. FCS was employed as these measurements
are noninvasive and yield detailed diffusion patterns. The
required ﬂuorescence labeling of the examinedmoleculeswas
achieved by reacting the cells with ﬂuorescently labeled
speciﬁc mAbs. As these measurements were performed at
24C on live cells, PBS containing 0.02% NaN3 was used to
prevent cytoskeleton motion.
One of the potential pitfalls of using divalent antibodies is
a possible clustering of the examined proteins induced by the
bivalent antibodies. To examine whether this affected our
experimental results, TCR diffusion was measured on the
surface of the CD81 T1.4 and CAS20 cells reacted with
either one of the following reagents: monovalent Fab frag-
ments of TCR b-chain speciﬁc mAb (clone H57) labeled
with Cy3 and a CD3-speciﬁc 17A2 mAb labeled with
CyChrome. For all FCS experiments, ﬂuorescence photo-
bleaching was observed at the initial stage of measurements.
This caused a drift in the ﬂuorescence baseline. The observed
photobleaching led us to investigate mobility of rafts by
monitoring diffusion of the raft-resident lipid ganglioside
GM1. For that, the cells were reacted with FITC-CTB, which
is known to speciﬁcally bind to GM1. The FITC-CTB ﬂuo-
rescence intensity exhibited photobleaching even at very low
excitation levels of the argon 488-nm line (5–10 mW) and
therefore the correlation function reﬂected the rate of the
FITC photobleaching rather than the rate of GM1 mobility
(not shown). Similar photobleaching was observed in FCS
experiments on rat basophilic leukemia cells (RBL)-2H3
where GM1 was reacted with CTB labeled by Cy3, a
ﬂuorescence probe possessing a signiﬁcantly higher photo-
stability than ﬂuorescein (33). Therefore, the observed
photobleaching is due to a slow mobility of GM1 and not
to the FITC-limited photostability. Thus, the raft diffusion
constant as implied by our observation was estimated to be
slower than 0.02 mm2/s, the rate that can be conﬁdently
detected in our experimental setup. In contrast to the CTB-
FITC measurements, ﬂuorescence photobleaching of the
labeled antibodies was observed only during the ﬁrst 20–40 s
after beginning of the measurements and then the ﬂuores-
cence intensity reached a steady-state level. This suggests
that only a fraction of CD8 or TCR molecules possesses
mobility too slow to be measured by FCS (,0.02 mm2/s)
whereas practically all GM1 molecules were ‘‘immobile’’.
In addition to the photobleaching, we observed processes,
which could also lead to baseline drifts, e.g., a slow
movement of the entire cell leading to a change in the point
of observation on the cell surface, or a cytoskeleton motion
induced by the excitation light. Therefore, special care has
always been taken to carry out the measurements at the
lowest possible excitation level on immobile cells. In
addition, the cells were maintained in the sodium azide-
containing buffer to prevent cytoskeleton motion. We
assume that taking all the above precautions, one can
conﬁdently study diffusion processes with rate constants
faster than 0.02 mm2/s. Quantitative investigation of slower
FIGURE 1 CTL cytotoxicity does not cor-
relate with TCR and CD8 expression levels.
(A) Expression levels of TCR and CD8 (traces
1, 2 and 3, 4, respectively) on the surface of
two CTL clones, CAS20 (traces 1, 3), and
CAS1 (traces 2, 4) as a function of the time
elapsed after cell stimulation. The cells were
stimulated every 1 or 2 weeks with the P815
targets transfected with HLA-Cw3 and human
b2-microglobulin in the presence of IL2 (20
units/ml). Harvested cells for ﬂow cytometry
were suspended at concentration 4 3 106 cell/
ml in PBS containing 3% fetal calf serum and
0.02% NaN3 and 100 ml aliquots were in-
cubated with 2 ml (1 mg/ml) of the CD3-
speciﬁc mAb (clone 17A2) labeled with
CyChrome or CD8-speciﬁc mAb (clone 53-
6.7) labeled with SPRD. After 40 min in-
cubation on ice, the cells were washed 33 and
analyzed immediately. (B) Fluorescence con-
focal images of CAS20 cells on the 4th and 9th
day after stimulation. As before, the cells were
reacted with SPRD-labeled CD8-speciﬁc mAb
(clone 53-6.7) and washed 33. (C) Cytotox-
icity of the CTL clone CAS20 raised against
P815 (H-2d) cells transfected with HLA-Cw3
and human b2-microglobulin. The lytic efﬁ-
cacy of the clone was tested at different E/T ratios in a 51Cr release assay against P815 (s) and RMA-S transfected with H-2Kd heavy chain, human
b2-microglobulin and pulsed with different concentrations of the cognate peptide pCw3: 1 mM (h), 5 mM (*), and 25 mM ()). In all cases, spontaneous
release was ,10% of total labeling. The experiments were performed on the 5th day after the cell stimulation. (D) Comparison of CTLs cytotoxicity (clone
CAS20) on the 4th (s) and 11th (h) days after stimulation for the P815 targets.
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processes on live cells was not feasible on the available FCS
instruments.
Diffusion measurements of TCR reacted with Fab frag-
ments or intact mAb were performed when the initial
photobleaching was ﬁnished. Representative ﬂuorescence
ﬂuctuation proﬁles and corresponding autocorrelation func-
tions are shown in Fig. 2, A–D (T1.4 CD81 cells) and Fig. 2,
G–J (CAS20). Very similar correlation functions were
observed for both the Fab fragments and intact mAb.
Diffusion parameters were derived by ﬁtting the correlation
functions to a three-component model (Eqs. 1 and 2). The
ﬁrst term accounts for diffusion of unbound antibodies or
FIGURE 2 Diffusion measurements
of TCR and CD8 on the surface of
T1.4 CD8ab1 (A–F) and CAS20 (G–L)
cells. The cellswere reacted on ice for 30
min with the respective speciﬁc ﬂuo-
rescently labeled Fab or mAbs and
washed 33. Measurements were made
at 24C within 5 min after cells loading
on the slides. Intensity ﬂuctuations
(A and G) and autocorrelation functions
(B and H) of Cy3-labeled Fab (clone
H-57) reacted with the cells. Intensity
ﬂuctuation (C and I) and correlation
functions (D and J) CyChrome-labeled
CD3-speciﬁcmAb (clone 17A2) reacted
with the cells. Intensity ﬂuctuations
(E and K) and autocorrelation functions
(F andL) of SPRD-labeledCD8-speciﬁc
mAb (clone 53-6.7) reacted with the
cells.
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Fab fragments, which are always present in such measure-
ments and the other two terms account for the lateral
diffusion. However, this ﬁtting is mathematically an ill-
posed problem, i.e., about equally good ﬁts could be
obtained to an experimental correlation function with
different sets of experimental parameters. To stabilize the
convergence, the value of the fastest diffusion rate constant,
corresponding to diffusion of free PE-labeled IgG-class
mAbs (150 kD IgG 1 240 kD PE) or the Fab fragments
(;50 kD) was kept constant at the expected values for this
molecular mass, i.e., 24 mm2/s or 46 mm2/s, respectively.
These values were experimentally determined in indepen-
dent three-dimensional FCS experiments. The 2D model
calculates these parameters with a relatively small systematic
error (,20%). This, however, did not signiﬁcantly affect
parameters of the second and third terms due to a large
difference between diffusion rates of the free and membrane-
bound molecules. The two other rate constants were assigned
to the lateral diffusion of two subpopulations of each of these
membrane-resident proteins.
The following diffusion rate constants (mm2/s) and their
respective amplitudes were calculated for the Fab fragment:
kD1¼ 46, a1¼ (76 5)%; kD2¼ 0.86 0.4, a2¼ (136 10)%;
kD3 ¼ 0.04 6 0.03, a3 ¼ (80 6 20)% on CD81 T1.4 cells
and kD1 ¼ 46, a1 ¼ (9 6 6)%; kD2 ¼ 0.9 6 0.4, a2 ¼ (33 6
20)%; kD3 ¼ 0.04 6 0.04, a3 ¼ (58 6 25)% (CAS20 cells).
Similar parameters were calculated for TCR reacted with the
intact mAb: kD1¼ 24, a1¼ (86 6)%; kD2¼ 0.76 0.4, a2¼
(16 6 8)%; kD3 ¼ 0.07 6 0.04, a3 ¼ (76 6 25)% (CD81
T1.4 cells), and kD1 ¼ 24, a1 ¼ (106 2)%; kD2 ¼ 0.76 0.3,
a2 ¼ (39 6 20)%; kD3 ¼ 0.03 6 0.02, a3 ¼ (51 6 20)%
(CAS20). This implies that possible clustering did not
signiﬁcantly affect the results obtained under the employed
experimental protocol when ﬂuorescence ﬂuctuations were
measured within 5 min after loading the cells onto a slide at
room temperature (24C). Fluorescence ﬂuctuations and
respective correlation functions for CD8 reacted with spe-
ciﬁc mAb (clone 53-6.7) labeled with SPRD are shown in
Fig. 2, E and F (CD81 T1.4 cells) and K and L (CAS20
cells). CD8 diffusion rate constants (mm2/s) and their res-
pective amplitudes were calculated: kD1¼ 24, a1¼ (56 2)%;
kD2¼ 0.86 0.3, a2¼ (466 20)%; kD3¼ 0.036 0.02, a3 ¼
(48 6 20)% for T1.4 CD81 cells and kD1 ¼ 24, a1 ¼ (6 6
3)%; kD2¼ 1.16 0.4, a2¼ (396 15)%; kD3¼ 0.086 0.05,
a3 ¼ (55 6 20)% for CAS20 cells. Thus, these FCS
measurements clearly resolved two subpopulations of the
CD8 and TCR molecules with signiﬁcantly different dif-
fusion rate constants (kD2 and kD3) and one with the diffusion
rate constant, which could not be measured in these FCS
experiments (,0.02 mm2/s). However, the differences be-
tween values of kD2 and kD3 determined for the rates of TCR
and CD8 diffusion were found to be nonsigniﬁcant statis-
tically (In t-test; p ¼ 0.60 for kD2 and p ¼ 0.22 for kD3 on
T1.4 CD81 cells and p ¼ 0.32 for kD2 and p ¼ 0.17 for kD3
on CAS20 cells).
Surface distributions of TCR and CD8 molecules and their
possible localization in membrane rafts were examined by
ﬂuorescence confocal microscopy. The cells were reacted
with either FITC-CTB together with the CD3-speciﬁc,
CyChrome-labeled mAb 17A2 or with the CD8-speciﬁc
mAb 53-6.7 labeled with SPRD in PBS buffer containing
0.02% NaN3 to immobilize the cytoskeleton and exclude its
possible involvement in raft aggregation. Nevertheless, GM1
patches labeled by CT-FITC were observed. This implies that
optically detectable rafts were present on the surface of both
CTL and the hybridoma cells. These patches exhibited
partial overlap with those labeled by either the CD3- or
CD8-speciﬁc labeledmAbs (SupplementaryMaterials, Fig. 1).
Real-time pMHC tetramer binding measurements:
the fast pMHC-CD8 association accelerates
tetramer binding to the cells
The observation by FCS measurements of three components
in the diffusion of TCR and CD8 molecules led us to suggest
that they correspond to their respective distinct subpopula-
tions on the cell’s membrane. To further investigate their
interactions with the pMHC ligand, association and disso-
ciation time courses of pMHC tetramers were carried out.
pMHC tetramers were employed as their avidity yields
higher binding than that of monomeric pMHC complexes
and allows monitoring these time courses directly.
First, interactions between H-2Kd/pCw3 tetramers and the
CTL clone CAS20 were studied. Maximal tetramer binding
amplitudes and biphasic time course were observed when
both TCR and CD8 molecules were available for the inter-
action (Fig. 3 A, trace 1). Then, CD8-pMHC interactions
were blocked by preincubating the cells (30 min at 24C)
with the CD8-speciﬁc mAb (CT-CD8a). This antibody was
found to bind to the immunoglobulin CDR-like loops of
CD8 involved in binding to the negatively charged loop of
the a3 domain of MHC class I and thereby blocks CD8-
pMHC interaction (34,35). When the cells were reacted with
CD8-speciﬁc mAb (CT-CD8a), the binding amplitude
dropped to only;10% of the previous case and only a single
binding phase was observed (Fig. 3 A, trace 2). The
speciﬁcity of the interactions was examined by loading the
tetramers with a noncognate peptide (pPbCSABA) and indeed
no binding was observed (Fig. 3 A, trace 5). Interaction rate
constants and amplitudes derived from analysis of the
respective time curves are listed in Table 1. These show that
when tetramers interacted only with the cell-surface TCRs
(i.e., when the CD8 was blocked by a speciﬁc mAb), the
observed single phase of association time course had a rate
constant of (1.1 6 0.4) 3 103 s1. When both CD8 and
TCR were available for the reaction, two binding phases
were resolved. The fast phase comprising ;50% of the total
binding amplitude had a rate constant of (3.3 6 0.7)3 103
s1, whereas that of the slow phase was about an order of
magnitude slower (4.56 2.0)3 104 s1. Thus, in the latter
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case, a faster overall binding process is observed with
markedly larger total amplitude. Similar results were
observed for H-2Kd/pPbCSABA tetramers association with
the T1.4 CD8ab1 hybridoma cells (traces 1 and 2 in Fig. 3 B
and Table 1). Finally, association rate constants of both fast
and slow phases increased upon increasing the tetramer
concentration from 8 to 25 nM (Table 2) implying that each
of them involves a second-order step.
Because FCS measurements resolved heterogeneous
diffusion of both TCR and CD8 in the plasma membrane,
we examined the possibility that the observed biphasic time
course of tetramer binding is related to this heterogeneity.
Speciﬁcally, the possible localization of CD8 and TCR in
distinct plasma membrane domains, e.g., rafts, was tested by
measurements of H-2Kd/pPbCSABA tetramer binding time
course to the T1.4 CD8ab1 hybridoma cells after their
treatment with MbCD (Fig. 3 B, trace 5). Tetramer binding
time course to the treated cells (trace 5, Fig. 3 B and Table 1)
was found to be monophasic with a 10-fold slower rate
constant than that of the fast binding phase observed in the
experiments using untreated cells (trace 1, Fig. 3 B and Table
1). Because cells’ treatment with MbCD depletes the mem-
brane’s cholesterol, and is assumed thereby to signiﬁcantly
affect the rafts (36), these results lend support to the above
FIGURE 3 Real-time measurements of pMHC tetramer interactions with T cells by ﬂow cytometry. (A) Association (traces 1 and 2) and dissociation (traces
3 and 4) time courses of PE-labeled H-2Kd tetramers loaded with the cognate peptide, pCw3, or the noncognate one, pPbCSABA (trace 5) to the CTL clone
CAS20 on the 2nd day after stimulation, studied by ﬂow cytometry at 24C. In the experiments illustrated by traces 2 and 4 the cells were preincubated for 30
min at 24C with the CD8-speciﬁc mAb (clone CT-CD8a; ﬁnal concentration 0.15 mM), which abrogates CD8-pMHC interactions. Tetramer concentration
was 20 nM. (B) Association (traces 1, 2, and 5) and dissociation (traces 3 and 4) time courses of PE-labeled H-2Kd tetramers loaded with a cognate peptide,
pPbCSABA, to the hybridoma cells transfected with T1 TCR and CD8ab. In the experiments illustrated by traces 2 and 4, the cells were preincubated as above
with the CD8-speciﬁc mAb. In the experiments illustrated by trace 5, the cells were preincubated with 5 mM MbCD for 1 h at 37C. Tetramer concentration
was 44 nM. (C) Binding time courses of PE-labeled H-2Kd/pCw3 tetramers to CTL clone CAS20 on different PS days: 3rd (trace 1), 5th (trace 2), 8th (trace 3)
day at 24C. The tetramer concentration was 11 nM. All traces were ﬁtted by one- or two-exponential models and the evaluated parameters are listed in Table 1.
TABLE 1 Parameters derived from analysis of the association/dissociation time courses of PE-labeled tetramers with/from T cells
Figure
(panel/trace)
Experimental
condition Reaction a0 3 10
1 a1 3 10
2 k1, s
1 3 103 a2 3 10
1 k2, s
1 3 104
3 A/1 CT-CD8a* Association 42 6 2 (2.2 6 0.1) 3.3 6 0.7 (20 6 1) 4.5 6 2.0
3 A/2 1CT-CD8a* Association 3.9 6 0.2 – – (3.9 6 0.2) 11 6 4
3 A/3 CT-CD8a* Dissociation 3.8 6 0.2 3.4 6 0.2 2.7 6 0.8 4 6 2 8.0 6 2.0
3 A/4 1CT-CD8a* Dissociation 1.2 6 0.1 – – 2.7 6 0.2 9.0 6 2.0
3 B/1 CT-CD8a* Association 56 6 3 (2.0 6 0.1) 7.5 6 1.0 (36 6 2) 2.4 6 0.6
3 B/2 1CT-CD8a* Association 6.0 6 0.3 – – (6.0 6 0.3) 1.0 6 0.6
3 B/3 CT-CD8a* Dissociation 0.3 6 0.1 3.6 6 0.2 1.6 6 0.4 16 6 1 3.0 6 0.4
3 B/4 1CT-CD8a* Dissociation 0.4 6 0.1 – – 3.0 6 0.3 4.0 6 0.6
3 B/5 1MbCDy Association 23 6 1 – – (23 6 1) 6.5 6 1.2
3 C/1 CT-CD8a* Association 44 6 2 (2.2 6 0.1) 2.1 6 0.5 (22 6 1) 2.5 6 0.8
3 C/2 CT-CD8a* Association 26 6 1 (2.1 6 0.1) 1.7 6 0.4 (6.2 6 0.3) 4.8 6 1.4
3 C/3 CT-CD8a* Association 18 6 1 (1.7 6 0.1) 1.6 6 0.4 (1.1 6 0.1) 3.5 6 1.0
The parameters were derived by ﬁtting the measured time courses shown in the following ﬁgures to a two-exponential model (Eq. 3) as described in Materials
and Methods. Fig. 3 A (traces 1–4) correspond to H-2Kd/pCw3 tetramer association with CTL (clone CAS20). Fig. 3 B (traces 1–4) correspond to H-2Kd/
pPbCSABA tetramer association with T1.4 CD8ab1 hybridoma cells. Fig. 3 B (trace 5) corresponds to H-2Kd/pPbCSABA tetramer association with T1.4
CD8ab1 hybridoma cells treated by MbCD. Fig. 3 C (traces 1–3) correspond to H-2Kd/pPbCSABA tetramer interaction with CTL (clone CAS20) on different
PS days. Further experimental details are presented in the legend to Fig. 3.
*The experiments were performed without () or with (1) the cells bound to the CD8-speciﬁc mAb (CT-CD8a) blocking CD8-pMHC interaction.
yCells treated by MbCD.
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notion that the heterogeneity in the binding time courses may
be due to CD8 and TCR subpopulations residing in distinct
membrane domains.
To examine whether the observed differences in the CD8
and TCR expression levels on the CTL clones affect the
ligand binding time courses, tetramer binding to CAS20 cells
was measured on different PS days (Fig. 3 C). The total
binding amplitude was found to be highest on the 3rd day.
This association time course was evaluated as above by the
two-exponential model. In this case, both amplitudes were
found to be about equal (a1  a2) (Table 1). Amplitudes of
the ﬁrst step (a1) remained virtually unaltered during the 3–8
day PS period whereas those of the second (a2) decreased to
24% on the 5th day and to 6% on the 8th PS day. The
observed changes in the total binding amplitudes (a1 1 a2)
were thus due to the decline of the second phase amplitude
(a2). Therefore, we can conclude that concentration of the
fast binding subpopulation of CD8 and TCR was virtually
independent on the time elapsed after stimulation whereas
that of the slow binding one was dependent.
Tetramer dissociation time courses from both CTL (clone
CAS20) and T1.4 CD8ab1 hybridoma cells were found to
be biphasic (traces 3, in Fig. 3, A and B, respectively, and
Table 1) when both CD8 and TCR were available for
binding. The largest number of the complexes (90% for CTL
and 80% for T1.4 CD8ab1) dissociated with the faster rate
constant (k1) and only a small fraction dissociated with the
slower one (k2). Only the respective slow phases of dis-
sociation were observed when the cells were preincubated
with the CD8-speciﬁc mAb (clone CT-CD8a) so that the
tetramers could only interact with the cell-surface TCRs
(traces 4 in Fig. 3, A and B, and Table 1). Thus, availability
of the CD8 coreceptor for tetramer binding increases sig-
niﬁcantly the total tetramer-cell association and hence also
their dissociation amplitudes. However, only ;10–20% of
the tetramers dissociate from the cells with a rate constant
similar to that observed when tetramers are exclusively
associated through the TCR-pMHC interactions.
DISCUSSION
In this study, we combined measurements of interaction
time courses and cell-surface diffusion to try and resolve the
mechanism whereby the CD8 coreceptor is involved in the
interactions between the pMHC and T cells. The FCS
measurements of CD8 and TCR revealed three components
in their lateral diffusion. The presence of a component with
a very slow diffusion rate is due to the observed initial
photobleaching in the FCS experiments. The presence of
such an ‘‘immobile’’ fraction can be rationalized by assum-
ing that the cell’s membrane is not a continuum of 2D ﬂuid
where all molecules can diffuse without any constrains. A
more recent model suggests that the membrane is separated
into compartments (37), and therefore diffusion of mem-
brane proteins can be restricted within the compartments’
borders. If the domains are smaller than the size of the
exciting laser beam’s waist, diffusion of CD8 and TCR
molecules does not produce ﬂuctuations in the ﬂuorescence
intensity and therefore they are observed as ‘‘immobile’’ in
the FCS experiments. Being continuously exposed to the
laser excitation, these molecules exhibit fast irreversible
photobleaching, which caused the ‘‘drift’’ of the ﬂuores-
cence intensity at the beginning of FCS measurements.
Similar ‘immobile’ fraction has been observed in ﬂuores-
cence photobleaching recovery experiments and assigned to
the presence of anomalously diffusing particles in small
domains of the membrane (38,39). Boundaries of these
small domains, restricting the protein mobility, could be
formed by, e.g., the actin-based membrane skeleton mesh
(40–42). Two ‘‘mobile’’ components were resolved. Their
diffusion rate constants were found to be insigniﬁcantly
different for both CD8 and TCR molecules (e.g., 0.8 6 0.3
and 0.05 6 0.03 mm2/s on the T1.4 CD8ab1 cells). The
rate constant of the slow diffusion component can be
assigned to the lateral diffusion in the ordered membrane
domains. This constant was slower that that reported for
TCR diffusion on Jurkat cells (0.12–0.15 mm2/s) (43). The
faster component has not been reported earlier and can be
assigned to the diffusion in the disordered membrane
domains. In both latter cases, CD8 and TCR mobility is
apparently not limited by the small size of the membrane
skeleton mesh, suggesting that it does not have a uniform
structure and some of its domains are larger than the size of
the illuminated spot, i.e., .0.2 mm. Results of the FCS
measurements of CTB-FITC show that indeed GM1
diffusion in the membrane is very slow, i.e., raft’s mobility
is very limited. This could be due to their interactions with
membrane cytoskeleton (33,44). Thus, we suggest that the
‘‘immobile’’ component corresponding to the diffusion of
CD8 and TCR molecules within the ‘‘small’’ rafts and the
resolved slower one, corresponding to diffusion of these
molecules in rafts of larger size, constitute the same
population because both of them are raft resident.
Therefore, only two substantially different subpopulations
of CD8 and TCR molecules associated with either rafts or
disordered membrane are present on the cell surface.
TABLE 2 PE-labeled H-2Kd/pCw3 tetramers binding to the CTL (clone Cas20)
[(pMHC)4], nM a0 3 10
2 a1 3 10
2 k1, s
1 3 103 a2 3 10
2 k2, s
1 3 103
25 4.0 6 0.2 (2.8 6 0.2) 3.9 6 0.8 (1.2 6 0.2) 1.1 6 0.4
8 3.8 6 0.2 (2.8 6 0.2) 1.3 6 0.5 (1.0 6 0.2) 0.22 6 0.08
The time courses were measured at 24C on the 6th day after stimulation at indicated tetramer concentrations.
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The confocal microscopy data also suggest distribution of
both CD8 and CD3 molecules between rafts and disordered
membrane microdomains. A partial localization of these
molecules within lipid raft domains is consistent with pre-
viously published results demonstrating an important role for
rafts and cytoskeleton in T-cell response to antigen stimu-
lation (44–50). Independent evidence for the existence of dif-
ferent CD8 and TCR subpopulations can also be derived from
the time courses of tetramer association with their speciﬁc T
cells. In the following,we shall elaborate on the notion that the
fast phase of tetramer association is due to tetramer inter-
actions with colocalized CD8 and TCR residing in rafts. The
slow association phase, observed in the experiments where
both CD8 and TCR were available for the interactions, is
apparently due to tetramer binding to noncolocalized TCR
and CD8. Our FCS experiments resolved three distinct com-
ponents in diffusion of CD8 andTCRmolecules.We interpret
these as reﬂecting three subpopulations in plasma membrane.
Two of these, we assume, correspond to CD8 and TCR
molecules residing in rafts of different sizes. Therefore, we
classiﬁed them as the same subpopulation suggesting similar
spatial relationship of CD8 and TCR molecules for both of
them. This, of course, does not mean that partitioning of CD8
and TCR molecules into rafts is the only mechanism respon-
sible for their proximity. Recent ﬁndings have clearly demon-
strated the important role of the cytoskeleton interactions with
membrane components in the cell’s function (44). Therefore,
interactions of both the CD8 and TCR with cytoskeleton may
also affect signiﬁcantly their spatial relationship.
Though tetramer association with T cells is a complex
multistep process involving multiple interactions between
the tetramer subunits and the surface-resident CD8 and TCR
molecules, two general points can be made. At the employed
reagent concentrations, association of soluble tetramers with
the cells is a sequential process starting with association of
one of the tetramer’s pMHC subunits with either CD8 or
TCR. Moreover, this ﬁrst step proceeds in three dimensions,
whereas all those following it, take place in the two
dimensions of the cell’s surface. Therefore, unless the CD8
and TCR are colocalized, these following steps have to
involve lateral diffusion of these molecules. Several routes of
tetramer association with the cells considered below.
pMHC-tetramer association with the TCR
To analyze our data, we ﬁrst assume that on a T cell with a
5-mm radius, the TCR is present with ;1 3 104 copies. We
also assume that they are distributed randomly on the cell’s
surface and no CD8 molecules are available when the
speciﬁc mAb is blocking their access. In this case, tetramer-
cell interaction will start with the association of one of the
tetramer’s pMHC subunits with a TCR. The next step,
association of the TCR-(pMHC)4 complex with a second
TCR, will usually require lateral diffusion. The mean time tc
between tetramer binding to the ﬁrst TCR and encountering
another TCR by diffusion in the membrane can be approx-
imated by the following expression (51):
tc ¼ 1:1a
2
ND
ln
1:2a
2
Ns
2
 
; (4)
where a is the cell’s radius, N is the number of TCR receptors
expressed on the cell surface, D is the TCR lateral diffusion
rate constant, and s is the distance between two TCRs at
which both of them can interact with the same tetramer.
Although this distance is an unknown parameter, a simple
geometrical consideration suggests that two TCR molecules
can simultaneously interact with the same tetramer when
they are separated by 4 3 103–6 3 103 mm. Because
tc dependence on s is less than linear, we have only 8%
uncertainty in the calculation of tc by taking s ¼ 5 3
103 mm. Inserting this value and N ¼ 1 3 104 molecules,
a ¼ 5 mm, and D ¼ 1 mm2/s, corresponding to TCR
diffusion in the bulk membrane, in Eq. 4, we calculate tc ¼
0.014 s. However, the production yield of the second
interaction with any TCR molecule approaching the distance
s is far from unity because of steric constraints; orientation of
the reaction partners needs to be adjusted so that their
encounter be productive. Therefore, we assume that tc will
be longer, at least by a factor 6–10, i.e., 0.08–0.14 s. This
means that a TCR, already bound to one tetramer subunit
will be at the distance s from another, properly oriented TCR
with a frequency of 7–13 s1. This will then be the frequency
of forming a (TCR)2-(pMHC)4. Because this reaction is not
diffusion limited and involves signiﬁcant structural changes
in the TCR binding site, which require an activation energy
(52), this value of the reaction rate constant is still reduced
further by a factor of ;102. Thus, the second association
step rate constant k29 will probably be reduced to ;0.1 s
1.
The ﬁrst-step rate constant k19 taken as the product of the
pMHC-TCR association rate constant k1 determined in
solution (7.0 3 103 M1s1) (29), at the employed tetramer
concentration (44 nM), is 3.1 3 104 s1. The dissociation
rate constant k1 of the recombinant, water-soluble TCR-
pMHC complex is ;0.2 s1 (29). The overall forward rate
constant of the following reversible two-step reaction:
ðpMHCÞ41 TCR k1
k1 TCR-ðpMHCÞ4
1 TCR 
k2
k2 TCR2-ðpMHCÞ4; (5)
can be calculated as:
kon ¼ k91 k92
k921 k1
: (6)
Inserting the values of k19, k29, and k1 in Eq. 6 we calculate
kon ¼ 1 3 104 s1, which agrees with the experimentally
observed values (Table 1, experiment 3 B/2).
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The role of CD8
As no binding of tetramers loaded with a noncognate peptide
could be resolved in the ﬂow cytometry binding experi-
ments, at least one TCR interaction should take place upon
association of a tetramer carrying a cognate peptide with the
cell. When both CD8 and TCR are available for interactions,
tetramers may react in the ﬁrst step of cell association with
either the TCR or CD8. However, the CD8-pMHC asso-
ciation rate constant has been determined in solution as
;1.5 3 105 M1s1 (18), i.e., ;20-fold faster than that
determined for the TCR T1–H-2Kd/pPbCSABA association
in solution (7.0 3 103 M1s1). Moreover, the CD8 cell-
surface expression level is approximately fourfold higher
than that of the TCR. Hence, the probability of tetramer’s
association ﬁrst with the cells’ CD8 is ;80-fold higher than
with the TCR. If ;4 3 104 copies of CD8 and ;1 3 104 of
TCR molecules are randomly distributed on a T cell, one can
calculate in a similar way to that done above, the rate con-
stant of a surface bound tetramer association with an addi-
tional CD8 as ;10 s1 and with a TCR as ;0.1 s1. Thus,
the tetramer association with an additional CD8 is by two
orders of magnitude faster than with a TCR. Therefore, in the
time window that one tetramer interaction with a TCR is
formed, two or three interactions with CD8 molecules will
take place. (We suggest that the maximal number of contacts
of a tetramer with cell-surface expressed CD8 or TCR is
three due to the tetramer’s tetrahedral geometry). The asso-
ciation rate constant of the ﬁrst step is a product of the CD8-
(pMHC)4 association rate constant (;1.5 3 10
5 M1 s1)
and the employed tetramer concentration (44 nM), namely
;6.6 3 103 s1. (We use the tetramer’s concentration
instead of the total concentration of the pMHC molecules
because in the ﬁrst step only one out of four tetramer’s
pMHC molecules can interact with cell-surface CD8). The
dissociation rate constant of the pMHC-CD8 complex in
solution was found to be ;20 s1 (18). Inserting these rate
constants of the ﬁrst and the second steps into the equation
for calculating the on-rate constant of the two-step reversible
reactions (Eq. 6), we obtain the rate of the (CD8)2-(pMHC)4
complex formation to be ;2 3 103 s1. The dissociation
rate of this or (CD8)3-(pMHC)4 complex from the cell are
not known, however, we may suggest that they are sig-
niﬁcantly slower than the dissociation of the CD8-pMHC
complex. Our experimental results show that tetramer’s
interactions with several CD8, in addition to that with the
TCR, increase signiﬁcantly the lifetime of its cell-associa-
tion. Indeed, the lifetime of the TCR T1-H-2Kd/pPbCSABA
complex as measured by the surface plasmon resonance
method was found to be 5 s (29), whereas the lifetime of the
(CD8)3-TCR-(pMHC)4 (as calculated from the fast phase of
tetramer dissociation from the cells) was more that two
orders of magnitude longer (630 s). A similar dramatic
increase in the lifetime has also been observed for
multivalent antigen association with cell-surface antibodies
(53). Thus, assuming that the dissociation rate of the (CD8)2-
(pMHC)4 complex is twice slower than that of CD8-pMHC,
i.e., 10 s1, the rate of (CD8)3-(pMHC)4 complex formation
will be ;7 3 104 s1. Further, let us assume that the
dissociation rate of (CD8)3-(pMHC)4 is similar to the rate of
tetramer association with the cell-surface TCR. Then, the
rate of (CD8)n-TCR-(pMHC)4 complexes formation will be
about equal to a product of the rates of (CD8)n-(pMHC)4
complexes formation (103–104 s1) and the rate of the
tetramer association with a TCR on the cell surface (0.1 s1),
i.e., 104–105 s1. Thus, assuming a random distribution of
CD8 and TCR, the rate for tetramer association with the cells
is expected to be signiﬁcantly slower than that of the
experimentally observed fast phase (7.5 3 103 s1,
experiment 3 B/1, Table 1) and agrees with the rate of the
slow phase (2.4 3 104 s1, experiment 3 B/1, Table 1).
These estimates show that if the TCR and CD8 are all
randomly distributed on the cell surface, their diffusion
limits the overall tetramer-cell association reaction rates.
Thus, the observed fast phase can be rationalized by ass-
uming that a subpopulation of proximal CD8 and TCR
molecules is present in the cell-surface membrane. A
relatively large body of published data (15,28,45,54–58)
and this confocal microscopy data suggest that some of the
CD8 and TCR molecules are localized in rafts, which
explains at least their partial nonrandom distribution on the
cell surface. Moreover, evidence for a constitutive associa-
tion of CD8 and TCR, i.e., colocalization has also been
published (59). Therefore, depending on the properties of
CD8-TCR associates and/or the raft size, their separation
distance may be signiﬁcantly shorter than that calculated
assuming their random distribution.
The above considerations allow the following interpreta-
tion of the results of the tetramer-cell interaction measure-
ments. Tetramer-cell association can proceed in several
different sequential routes with the ﬁrst step proceeding in
three dimensions, i.e., from solution to the cell surface.
Taking this into account and assuming that the ﬁrst step
determines the rate of the overall reaction, its experimentally
observed rate is a pseudo-ﬁrst-order one, i.e., a product of the
speciﬁc rate constant, k1, and tetramer concentration. Thus,
we calculate the value of k1 as (1.76 0.2)3 10
5 M1 s1 at
24C. This value is found to be essentially the same for both
the hybridoma and CTL cells. The close values of these rate
constants for the interactions of different cell types
expressing distinct TCRs with pMHC tetramers loaded
with different peptides suggest that this interaction is not
clone speciﬁc. Moreover, these rates are close to that
reported for the association rate constant of soluble CD8 and
pMHC molecules (1–2 3 105 M1 s1) (18) yet are much
faster than that of soluble H-2Kd/pPbCSABA binding to the
T1 TCR (7.0 3 103 M1 s1) at 25C (29). In addition, the
fast phase disappeared when CD8 access was blocked by
a speciﬁc mAb. All these led us to conclude that the observed
fast phase of tetramer association with the cells is primarily
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due to a binding process starting by (pMHC)4 association
with the CD8. It is followed by association of the CD8-
(pMHC)4 complex with additional one (or two) CD8 and at
least one TCR. As the rate of this ﬁrst step determines the
overall rate of the tetramer binding to the cells, we conclude
that the rates of the following steps on the cell surface are
faster than the dissociation rate constant of the CD8-
(pMHC)4 complex, which is possible only for colocalized
CD8 and TCR. Thus, our kinetic data suggest that at least
some of the CD8 and TCR molecules are colocalized.
Biphasic tetramer association was also observed with the
CTLs. This is similarly interpreted by the presence of essen-
tially two subpopulations of CD8 and TCR molecules on the
CTL surface. The amplitudes of the fast tetramer association
phase with the CTL were found to be practically independent
of the time elapsed after cell stimulation, whereas those of
the slow phase decrease signiﬁcantly at the later PS days.
The fast reacting subpopulation of the assumed colocalized
CD8 and TCR molecules remains constant and the sub-
population reacting in the slow phase, decreased on the late
PS days. As the signiﬁcant reduction in the CD8 and TCR
expression levels of the slow binding subpopulation did not
decrease the cells’ cytotoxicity, we suggest that only these
molecules reacting in the fast phase lead to T-cell activation.
Thus T cells with similar expression levels of TCR and CD8,
may exhibit signiﬁcantly different cytotoxic capacity, which
depends on their spatial relationship on the cell’s membrane.
The rate of tetramer association with the MbCD treated
cells was found to be ;10-fold slower than that of the fast
binding phase when both CD8 and TCR are available for the
interactions on untreated cells. This implies that MbCD
treatment changes the CD8 and TCR spatial relationship.
However, this rate is still faster than that of tetramer
association with the cells when the CD8-pMHC interaction
was blocked. This suggests that even on the MbCD treated
cells, CD8 molecules are involved in the initial step of
tetramer association and certain proximity between TCR and
CD8 is maintained.
The fact that no binding of H-2Kd tetramers loaded with
the noncognate peptide (pPbCSABA) was observed to the
CTLs is contrasted by several examples of reported ‘‘non-
speciﬁc’’ multimer binding to T cells (60). Our model
suggests that the CD8-pMHC interaction can signiﬁcantly
promote binding of low afﬁnity ligands. Therefore, the CD8-
TCR cooperation combined with the TCR binding site’s
remarkable plasticity is probably the cause for the cross-
reactivity of T cells. We suppose that in this case, binding of
H-2Kd/pPbCSABA tetramers to the CAS20 CTLs was not
observed because of a rather low afﬁnity of H-2Kd/
pPbCSABA for the TCR of Cas20 cells.
Dissociation rate of the surface-associated (pMHC)4
depends on the number of pMHC-TCR and pMHC-CD8
interactions produced. Due to the avidity of this interaction,
binding can reach the saturation level in the nanomolar
tetramer concentration range. Indeed, at 107 cell/ml and 104
TCRs expressed on one cell, the total number of TCRs in 1
ml reaches 1011, which corresponds to a concentration of
;0.2 nM. Thus, one can expect that all TCRs will be bound
at tetramer concentration as high as ;10 nM. When
saturating tetramer concentrations are employed, one can
expect a competition for the TCR binding sites. As a result,
a distribution of the number of pMHC-TCR contacts per
tetramer is expected, which should manifest itself as a
multiphasic dissociation time course. This conclusion is
consistent with the biphasic tetramer dissociation observed
in the experiments where both CD8 and TCR were available
for the interactions. These phases are therefore assigned to
dissociation of tetramer-cell complexes having several CD8
interactions and differing in the number of pMHC-TCR
interactions: one for the faster dissociation phase and two or
three for the slower ones. In experiments, where CD8 were
blocked and only the TCRs interacted with the tetramers,
only a single dissociation phase has been observed with a rate
close to that of the slow phase in the experiments where both
CD8 and TCR were available for interaction. In this case,
only tetramers interacting with at least two TCRs were
probably monitored due to the limited temporal resolution of
the employed experimental protocol.
In summary, we propose that the most efﬁcient route of the
ligand binding starts with CD8-pMHC interaction. This is
followed by association of the CD8-pMHC complex with the
TCR. Thus, the role of CD8 in this process is accelerating the
pMHC-cell association by increasing the probability of this
ligand’s encounters with the TCR. This mechanism would
universally operate in the binding irrespective of the TCR
afﬁnity for a given pMHC. However, it would be of special
importance for low afﬁnity interactions because the TCR-
ligand binding has been shown to be a relatively slow
process because of the signiﬁcant conformational transitions
induced in the TCR binding site.
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